Levy, W. C., D. Mozaffarian, D. T. Linker, S. C. Sutradhar, S. D. Anker A. B. Cropp, I. Anand, A. Maggioni, P. Burton, M. D. Sullivan, B. Pitt, P. A. Poole-Wilson, D. L. Mann, and M. Packer. 2006. The Seattle heart failure model: Prediction of survival in heart failure. Circulation 113(11):1424–1433.

Lloyd-Jones, D., R. J. Adams, T. M. Brown, M. Carnethon, S. Dai, G. De Simone, T. B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P. M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M. M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V. L. Roger, W. Rosamond, R. Sacco, P. Sorlie, R. Stafford, T. Thom, S. Wasserthiel-Smoller, N. D. Wong, J. Wylie-Rosett, and on behalf of the American Heart Association Statistics Committee Stroke Statistics Subcommittee. 2010. Heart disease and stroke statistics—2010 update: A report from the American Heart Association. Circulation 121(7):e46–e215.

Redfield, M. M., S. J. Jacobsen, J. C. Burnett Jr., D. W. Mahoney, K. R. Bailey, and R. J. Rodeheffer. 2003. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. Journal of the American Medical Association 289(2):194–202.

SSA (Social Security Administration). 2008. Listing of impairments—Adult listings (Part A). Disability evaluation under Social Security (Blue Book). http://www.socialsecurity.gov/disability/professionals/bluebook/AdultListings.htm (accessed July 22, 2010).

Stevenson, L. W., G. Couper, B. Natterson, G. Fonarow, M. A. Hamilton, M. Woo, and J. W. Creaser. 1995. Target heart failure populations for newer therapies. Circulation 92(9 Suppl):II 174–181.

Wilson, J. R., G. Rayos, T. K. Yeoh, and P. Gothard. 1995. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. Journal of the American College of Cardiology 26(2):429–435.

Zile, M. R., and J. Nappi. 2000. Diastolic heart failure. Current Treatment Options in Cardiovascular Medicine 2(5):439–450.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement